4/A//SEC Filing
Nussbaum Ran 4/A
Accession 0001437749-23-004870
CIK 0001668243other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 12:29 PM ET
Size
7.0 KB
Accession
0001437749-23-004870
Insider Transaction Report
Form 4/AAmended
Nussbaum Ran
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2022-06-06$5.00/sh+1,030$5,150→ 1,434,958 total(indirect: Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd.) - Exercise/Conversion
Stock Option (right to buy)
2022-06-06−1,030→ 0 total(indirect: By Partnership)Exercise: $5.00From: 2015-09-01Exp: 2022-09-01→ Ordinary Shares (1,030 underlying)
Footnotes (2)
- [F1]On August 25, 2022, the reporting person filed a Form 4 that inadvertently reported 1,433,928 shares of securities beneficially owned following reported transaction instead of 1,434,958 shares.
- [F2]On August 25, 2022, the reporting person filed a Form 4 that inadvertently list the expiration date as August 31, 2022.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001609805
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 12:29 PM ET
- Size
- 7.0 KB